ArticleBMC microbiology2025
Genome sequencing and physiological characterization of three Neoarthrinium moseri strains.
Article in BMC microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundFungi play essential ecological roles and have been utilized by humans for diverse applications such as industrial enzyme production or as sources of bioactive compounds. Recent research has highlighted the Amphisphaeriales order (Ascomycota) as promising producers of secondary metabolites of pharmaceutical importance. Within this family, the recently established genus Neoarthrinium includes species such as N. brasiliense, N. lithocarpicola, N. moseri, N. trachycarpi, and N. urticae. Existing literature has primarily focused on the taxonomy and phylogeny of Neoarthrinium, leaving its physiology, ecology, and metabolic potential unexplored.
resultsThis study presents the first investigation of the metabolic and genomic potential of N. moseri. We describe the isolation of two South-Asian N. moseri strains and the genome sequencing of these strains alongside the Colombian ex-type strain for the species. Comparative genome analysis reveals an exceptionally high number of biosynthetic gene clusters (BGCs), surpassing those of many other fungi in the Amphisphaeriales order. Additionally, the genome of N. moseri contains a diverse repertoire of carbohydrate-active enzymes (CAZymes), supporting its hypothesized ecological role as a phyllosphere fungus (putatively an endophyte and/or saprotroph). Ecophysiological assays, including BIOLOG phenotyping, demonstrate its ability to utilize a broad range of carbon sources, emphasizing ecological versatility.
conclusionsThis study highlights N. moseri as a promising candidate for secondary metabolite discovery, providing foundational insights into the metabolic and genomic potential of the Neoarthrinium genus and related fungi.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.